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Abstract 
SLC4A11 mutations are associated with Fuchs’ endothelial corneal dystrophy (FECD), congenital 
hereditary endothelial dystrophy (CHED) and Harboyan syndrome (endothelial dystrophy with auditory 
deficiency). Mice with genetically ablated Slc4a11 recapitulate CHED, exhibiting significant corneal edema and 
altered endothelial morphology. We recently demonstrated that SLC4A11 functions as an NH3 sensitive, 
electrogenic H+ transporter. Here, we investigated the properties of five clinically relevant SLC4A11 mutants: 
R125H, W240S, C386R, V507I and N693A, relative to wild type, expressed in a PS120 fibroblast cell line. The 
effect of these mutations on the NH4Cl-dependent transporter activity was investigated by intracellular pH and 
electrophysiology measurements. Relative to plasma membrane expression of Na-K ATPase, there were no 
significant differences in plasma membrane SLC4A11 expression among each mutant and wild type. All 
mutants revealed a marked decrease in acidification in response to NH4Cl when compared to wild type, 
indicating a decreased H+ permeability in mutants. All mutants exhibited significantly reduced H+ currents at 
negative holding potentials as compared to wild type. Uniquely, the C386R and W240S mutants exhibited a 
different inward current profile upon NH4Cl challenges, suggesting an altered transport mode. Thus, our data 
suggest that these SLC4A11 mutants, rather than having impaired protein trafficking, show altered H+ flux 
properties.  
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SLC4A11 has been identified to be a member of Solute Carrier 4 (SLC4) family of bicarbonate 
transporters. It was initially reported to function as an electrogenic membrane transporter for Na+-coupled 
borate (Park, Li et al. 2004), however recent studies indicate that human SLC4A11 does not transport 
bicarbonate or borate (Jalimarada, Ogando et al. 2013; Kao, Azimov et al. 2016; Loganathan, Schneider et al. 
2016; Ogando, Jalimarada et al. 2013). We have provided evidence that SLC4A11 has H+ permeability that is 
activated by ammonia and is directly proportional to [NH3]o not [NH4+]o, and is relatively unaffected by 
removal of Na+, K+, or Cl- (Zhang, Ogando et al. 2015). 
Several mutations in SLC4A11 have been reported to be associated with Fuchs’ endothelial corneal 
dystrophy (FECD), congenital hereditary endothelial dystrophy (CHED2) and Harboyan syndrome (endothelial 
dystrophy with auditory deficiency). Specifically, the C386R and R125H mutants of SLC4A11 are found in 
patients with autosomal recessive Congenital Hereditary Endothelial Dystrophy, whereas the V507I and W240S 
mutants of SLC4A11 are linked to Fuchs endothelial corneal dystrophy (Ramprasad, Ebenezer et al. 2007; 
Riazuddin, Vithana et al. 2010; Vithana, Morgan et al. 2006). Corneal endothelial dystrophy and the associated 
dysfunction of the corneal endothelial cells may lead to corneal edema and blindness in humans that currently 
can only be treated by corneal transplant.  
The R125H and W240S mutations are both localized in the SLC4A11 N-terminal cytoplasmic domain. 
C386R and V507I mutations are localized in the 1st or 5th transmembrane domains respectively, whereas N639A 
is located in extracellular loop 4. It has been reported that some SLC4A11 mutations may cause dysfunction of 
the protein and/or reduced trafficking to the plasma membrane (Alka and Casey 2018; Alka and Casey 2018; 
Chiu, Mandziuk et al. 2015; Vilas, Loganathan et al. 2013; Vilas, Loganathan et al. 2012; Vithana, Morgan et 
al. 2008). Function of mutants has been tested by measuring changes in water flux (Alka and Casey 2018; Chiu, 
Mandziuk et al. 2015; Vilas, Loganathan et al. 2013), which is small relative to aquaporins, in HEK cells or 
Xenopus oocytes and electrophysiologically using the R109H mouse mutant in Xenopus oocytes (Myers, 
Marshall et al. 2016).  
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In this study, we stably expressed the five human SLC4A11 mutants (R125H, W240S, C386R, V507I 
and N693A) representing two N-terminal, two transmembrane and one extracellular loop mutants, respectively. 
The R125H was included as a potentially dysfunctional mutant (Vilas, Loganathan et al. 2013). The hamster 
fibroblast (PS120) cell line that lacks the Na+- H+ exchanger (NHE) was used for transfection. This cell line is 
used because NHE complicates the investigation of proton fluxes via SLC4A11 (Barriere, Poujeol et al. 2001; 
Ogando, Jalimarada et al. 2013). We investigated the effect of these mutations on trafficking by plasma 
membrane protein isolation with reference to the major plasma membrane Na-K-ATPase and functional 
properties of the SLC4A11 by patch-clamp electrophysiology.  
Human SLC4A11 cDNA was cloned in frame with the hemagglutinin epitope (HA)-tag and was inserted 
into the phCMV vector. Five single amino acid changes were individually made using the QuikChange 
Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, CA). Mutated SLC4A11 variants are referred 
to as R125H, W240S, C386R, V507I, and N639A respectively. To generate these mutants, the following 
nucleotide changes were made: G374A, G719C, T1157C, G1519A, and AA(1915, 1916)GC, respectively. All 
mutations were confirmed by DNA sequencing at ACGT, Inc. (Wheeling, IL). Primer sequences used for 
generating mutations are provided in Table 1. The nucleotides and positions of the mutations are indicated.  
Hamster fibroblast (PS120) cells were cultured in DMEM supplemented with 5% fetal bovine serum, 
and transfected with the SLC4A11 plasmids using Lipofectamine 3000 (Invitrogen). The cells, which were 
stably expressing the SLC4A11 mutants, were selected by Geneticin at 1 mg/ ml in culture medium. The details 
of the transfection procedure are described elsewhere (Ogando, Jalimarada et al. 2013). PS120 cells stably 
expressing wild-type SLC4A11 plasmid (WT) or the empty vector plasmid (EV) were used as controls.   
PS120 cell surface proteins were linked to sulfo-NHS-SS-Biotin (Pierce, Rockford, IL) according to the 
manufacturer’s instructions. In brief, transfected PS120 cells grown in two T-75 flasks were incubated with 
sulfo-NHS-SS-biotin (0.25 mg/ml) at 10 ml/flask for 30 min at 4°C. The cells were washed 3 times with ice-
cold PBS and then lysed in 500 µl of lysis buffer [5 mM EDTA, 150 mM NaCl, 1% (vol/vol) Igepal, 0.5% 
(wt/vol) sodium deoxycholate, 10 mM Tris·HCl, pH 7.5 and protease inhibitors]. The lysate was sonicated at 
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low power on ice. After a 10-min centrifugation (10,000 g at 4°C), the supernatant was collected and incubated 
with 500 µl of NeutrAvidin Agarose for 1 h with rocking at room temperature. The resin was collected by 
centrifugation at 1,000 g and washed three times with the wash buffer provided with the kit. The supernatant 
and wash, representing the non-membrane fraction, were collected and saved. Finally the bound proteins were 
eluted with 400 µl of 2 × SDS sample buffer. 
Both fractions (20 µg per lane) were resolved on SDS-PAGE gels. The biotinylated SLC4A11 protein 
was detected using the anti-HA antibody (Covance Inc. Alice, TX). A plasma membrane protein, Na+/K+-
ATPase, was used as internal control to normalize the SLC4A11 protein amount in the tested lysate samples. 
The anti (α-1 subunit) Na+/K+-ATPase antibody was from Cell Signaling (#3010). Both membrane and non-
membrane fractions were probed for Endoplasmin (GRP94, Bio-Rad #VPA00059), an ER resident protein, and 
for GAPDH in order to validate the biotinylation procedure. Blot densitometry analysis was performed using 
the software “Image Lab 6.0” (BIO-RAD). 
To measure intracellular pH (pHi), PS120 cells that had been transfected with SLC4A11 constructs were 
grown on poly-lysine coated coverslips. At about 80% confluence, cells were loaded for 30 minutes at room 
temperature with a pH sensitive fluorescent dye of 2′,7′-bis-(2-carboxyethyl)-5-(6)-carboxyfluorescein 
acetoxymethyl ester (BCECF AM, 10 µM, Invitrogen, CA), which was diluted from a 10 mM DMSO stock in a 
bicarbonate-free buffer (BF Ringer) of the following composition in mM: 105 NaCl, 10 NMDG-Cl, 2 KCl, 0.61 
MgCl2, 1 K2HPO4, 28.5 Na+-Gluconate, 1.4 Ca2+-Gluconate, and 10 HEPES. The coverslip was washed for 30 
minutes in fresh BF ringer and then mounted in a custom-designed perfusion chamber. BF Ringer was used as 
the standard bathing solution (pH 7.5 and osmolality 295). The NH4Cl perfusion solution was prepared by 
substituting 10 mM NMDG- l with 10 mM NH4Cl in BF Ringer. The perfusion chamber was maintained at 37 
°C using a circulating water bath. The perfusion flow rate was kept to ~0.5 ml/min by gravity. Perfusion of 
NH4Cl-BF Ringer was conducted for 5 minutes in all experiments. BCECF fluorescence (Ex 495 and 440nm, 
Em 520-550nm) was captured using an inverted microscope (Eclipse TE200, Nikon, Japan) equipped with the 
oil-immersion 40x objective. The fluorescence was recorded and analyzed using Felix 32 Software. The 
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fluorescence emission ratio (Ex 495/Ex440) was obtained at 1 Hz and converted to pH via calibration with high-
K+-nigericin (26 µM) in Ringer (Ogando, Jalimarada et al. 2013). All rates of pHi change (∆pHi/∆t) were 
calculated from the initial 20 seconds following a perfusion change.  
The whole-cell patch clamp technique was used to measure NH4Cl-induced currents through SLC4A11 
and mutants as described elsewhere (Zhang, Ogando et al. 2015). Briefly, whole cell currents were amplified 
using an Axopatch 200B integrating patch-clamp amplifier and digitized using a Digidata 1400 analog-to-
digital converter (Molecular Devices, CA). Currents were filtered at 3 kHz using the internal filter of Axopatch 
200B and sampled at a rate of 1 kHz. The patch-clamp data were analyzed using the pCLAMP 10 software 
package. The extracellular solution for electrophysiological recordings contained (in mM): 145 NaCl, 2.5 KCl, 
2. CaCl2, 1 MgCl2, 10 HEPES, and 5.5 glucose (pH 7.5 or 8.5, adjusted with NaOH). The pipette solution
contained in mM: 125 CsMeSO3, 3.77 CaCl2, 2 MgCl2, 10 EGTA (100 nM free Ca2+), and 10 HEPES (pH 7.2 
adjusted with Trizma base). The 10 mM NH4Cl was always made fresh before the experiments began. The 
current density (pA/pF) was calculated by dividing the current amplitude by the cell capacitance. All salts were 
purchased from Sigma-Aldrich. Data were analyzed by one-way ANOVA test. They are shown as mean values 
± standard deviation. P < 0.05 was considered significant.    
Figure 1A shows a representative blot of plasma membrane SLC4A11 expression referenced to Na+/K+ 
ATPase in the biotinylated fraction. Figure 1B shows the summary results from three experiments. The ratio of 
biotinylated-SLC4A11 to biotinylated-Na+/K+ ATPase in Wild Type transfected cells was 0.9. The ratio in the 
five mutants was not significantly different indicating that those mutants were able to traffic to the plasma 
membrane. The membrane biotinylation and isolation procedure was validated by probing biotinylated 
(membrane) and non-biotinylated (cytosolic) fractions for Endoplasmin (GRP94), an ER lumen resident protein 
and GAPDH, a cytosolic protein. Membrane/cytosolic ratios of GRP94 were approximately 6% and GAPDH 
less, indicating that there was good separation and little contamination of membrane fractions with ER protein 
or soluble cytosol. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
7 
 
The ammonia sensitive H+ flux properties of SLC4A11 were first described using intracellular pH 
measurements. Figure 1C shows NH4Cl-induced pHi changes in PS120 cells that had been transfected with WT-
SLC4A11, mutant variants, and EV (empty vector). The baseline pHi (Figure 1D) was lowest (7.17 ± 0.06) in 
WT-SLC4A11 and highest in EV (7.81 ± 0.09), consistent with previous findings (Jalimarada, Ogando et al. 
2013; Ogando, Jalimarada et al. 2013; Zhang, Ogando et al. 2015), and is attributed to small background 
electrogenic H+ influx generated by SLC4A11 (Kao, Azimov et al. 2015; Kao, Azimov et al. 2016; Myers, 
Marshall et al. 2016; Zhang, Ogando et al. 2015). The five mutants displayed baseline pHi in between WT-
SLC4A11 and EV. The pHi increased sharply when cells were exposed to NH4Cl. Alkalinization rates 
(∆pHi/min) were converted to H+ flux (Figure 1E) (Flux=dpH/dt * βι), where βι is intrinsic buffering capacity, 
which is a function of pHi (β=a*EXP(-b*pHi)+c*EXP(-d*pHi), where a=0.364, b=-0.466, c=7E9, and d=3.04 
(buffering data deposited in Menedlay). Cell acidification rates in the presence of NH4Cl were also converted to 
H+ flux (Figure 1F). H+ fluxes and the total acidification following removal of NH4Cl (Figure 1G) was WT > 
C386 > W240 > R125 > V507 > N639 >EV. Total acidification represents the ultimate effect of the NH4Cl 
pulse, and it confirmed that SLC4A11 transporter activity and its ability to affect H+ flux was compromised by 
the mutations.  
We next performed electrophysiological recordings in PS120 cells stably expressing WT-SLC4A11 or 
mutants. The electrophysiological data revealed that NH4Cl-induced currents in PS120 cells stably expressing 
the tested SLC4A11 mutants exhibited significantly reduced average amplitudes compared to that observed in 
the WT-SLC4A11-PS120 cells (Fig. 2A-G) in both pH 7.4 (Fig. 2I) and pH 8.5 (Fig. 2H) solutions. In pH 8.5 
solution, PS120 cells stably expressing R125H (Fig. 2E), V507I (Fig. 2F) or N639R (Fig. 2G) mutants 
exhibited NH4Cl-induced inward currents indistinguishable from those observed in PS120 cells stably 
expressing the empty vector. While all mutant currents were significantly suppressed, the mean amplitude of 
inward currents in the C386R-SLC4A11-PS120 cells and W240S- SLC4A11-PS120 cells (Fig. 2C and 2D, 
respectively) was significantly greater than that found in the empty vector at pH 8.5 (Fig. 2H), but not pH 7.5 
(Fig 2I). Interestingly, extracellular alkalinization alone (Fig. 2J) induced small inward currents in C386R-
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SLC4A11-PS120 cells and W240S-SLC4A11-PS120 cells. Uniquely, no characteristic changes in the current 
flow direction upon re-addition of pH 7.5 solution after an NH4Cl extracellular pulse were observed in C386R-
SLC4A11-PS120 and W240S-SLC4A11-PS120 cells in sharp contrast to WT-SLC4A11-PS120 cells after an 
NH4Cl pulse (Fig. 2K). Alkalinization of the extracellular solution to pH 8.5 did not affect baseline currents in 
wild type SLC4A11, V507I, R125H or N639A mutant expressing PS120 cells before a second NH4Cl pulse, but 
increased the baseline current in C386R-SLC4A11-PS120 and W240S-SLC4A11-PS120 cells (Fig. 2A-G). The 
NH4Cl-induced currents recorded at pH 7.4 and pH 8.5 in WT-SLC4A11-PS120 cells were reversing at 
significantly different membrane potentials of +15.2 ± 2.4 and -17.2 ± 5.2 mV, respectively. In sharp contrast, 
the reversal potentials of NH4Cl-induced currents were not significantly different in C386R-SLC4A11-PS120 
and W240S-SLC4A11-PS120 cells when the currents were measured under the same conditions (C386R: -7.8 ± 
3.5 mV at pH 7.5 and -11.8 ± 6.8 mV at pH 8.5; W240S: -19.1 ± 4.4 mV at pH 7.5 and -17.8 ± 2.9 mV at pH 
8.5; Fig. 2H inset). These data indicate that at least two of the tested mutants, C386R and W240S, appear to be 
functional but exhibit altered electrophysiological properties.  
In this study, we found that five mutations R125H, W240S, C386R, V507I and N639 in human 
SLC4A11 altered intracellular pH homeostasis to varying degrees in transfected PS120 cells. It has been 
proposed that these functional differences could be due to impaired protein trafficking to the plasma membrane 
and in part due to a reduction in the functional electrogenic H+ transport property of SLC4A11 mutants (Alka 
and Casey 2018; Vilas, Loganathan et al. 2012). We found that in the PS120 expression model, the protein 
amounts in the plasma membrane were not significantly different among WT and mutants, indicating that these 
mutations did not interfere with protein trafficking. Our data differ from a previous report proposing that C386R 
and W240S proteins are retained in the endoplasmic reticulum (Vilas, Loganathan et al. 2012). This discrepancy 
may be due to the fact that different expression models were used (transiently transfected HEK293 vs stably 
expressing PS120 cells in the current study) or the approach: Vilas et al. show total and unbiotinylated fractions, 
calculating the difference as surface expression and using GAPDH as the internal reference (Vilas, Loganathan 
et al. 2013), and more recently used a bioluminescence resonance energy transfer assay (Alka and Casey 2018), 
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while in our study we blot the biotinylated plasma membrane fraction directly with reference to Na+/K+ 
ATPase.  
SLC4A11 confers NH3-dependent H+ fluxes (Kao, Azimov et al. 2016; Zhang, Ogando et al. 2015). We 
found that intracellular pH responses to NH4Cl pulses were altered in the mutants. The intracellular rates of 
alkalinization/acidification are lower for all of the SLC4A11 mutants. The rate of acidification in NH4Cl 
represents the NH3 sensitive H+ influx (Fig. 1E). The rank order of function was WT> C386R> W240S> 
R125H> V507I = N693A >EV. From the electrophysiological recordings, all mutants showed significantly 
lower NH4Cl induced currents than WT. For patch-clamp data the rank is WT> C386R> W240S> R125H = 
V507I =N693A >EV, which is essentially the same as the pHi data.  
Conclusion 
Five SLC4A11 mutants that are associated with corneal endothelial dystrophy exhibit markedly reduced 
NH3 sensitive electrogenic H+ transport activity, with plasma membrane protein expression being unaffected in 
a PS120 stable transfection model. The intracellular pH rates of alkalinization/acidification in the mutants show 
a reduced amount of functionality when compared to the wild-type SLC4A11. Our data support the hypothesis 
that reduced and altered functional activity of some SLC4A11 mutants rather than membrane trafficking may 
underlie corneal endothelial dystrophy in patients expressing these mutations. However, there are over sixty 
SLC4A11 missense mutants and whether dysfunction is due to poor trafficking or activity needs further testing. 
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Table 1. PCR primers used for SLC4A11 Mutagenesis. 
Mutation Primers (5’ -> 3’) 
R125H Forward: AACTTCAAGGAAGAGATCCATGCGCACCGCGACCTAGAT 
Reverse:  ATCTAGGTCGCGGTGCGCATGGATCTCTTCCTTGAAGTT 
W240S Forward: CACAGAACTCGGGGGAGAATTCCTGTGAGGTTC 
Reverse:  GAACCTCACAGGAATTCTCCCCCGAGTTCTGTG 
C386R Forward: CTGTTCCTCTACTTCGCCCGCCTCCTG 
Reverse:  CAGGAGGCGGGCGAAGTAGAGGAACAG 
V507I Forward: CATCACGTTTGTGCTGGATGCCATCAAGGGCAC 
Reverse:  GTGCCCTTGATGGCATCCAGCACAAACGTGATG 
N639A Forward: GATGAGCAAGTTCCGCTACGCCCCCAGCGAGAG 
Reverse:  CTCTCGCTGGGGGCGTAGCGGAACTTGCTCATC 
Mutated nucleotides were indicated by underline. 
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Table 2.  SLC4A11 and mutants current densities (a-e are indicated in Fig. 2). 
Current Densities 
(pA/pF) 
P (vs WT) P (vs EV) 
WT 
(n=17) 
a -6.42 ± 1.67 N.C.
N.C.
N.C.
N.C.
N.C.
P<0.05 
N.S. 
P<0.001 
N.S
P<0.05 
b 1.04 ± 0.36
c -22.09 ± 2.24
d -1.92 ± 0.61
e -4.60 ± 0.50
C386R 
(n=8) 
a -0.97 ± 0.51 P<0.05 P<0.05 
b -0.38 ± 0.30 P<0.05 N.S. 
c -3.00 ± 0.63 P<0.001 P<0.05 
d -3.93 ± 0.97 P<0.05 P<0.05 
e -4.05 ± 0.99 N.S P<0.05 
W240S 
(n=8) 
a -0.56 ± 0.28 P<0.05 N.S. 
b -0.30 ± 0.19 P<0.05 N.S. 
c -1.64 ± 0.24 P<0.001 P<0.05 
d -1.28 ± 0.29 N.S. N.S. 
e -1.23 ± 0.32 P<0.05 P<0.05 
R125H 
(n=6) 
a 0.12 ± 0.19 P<0.05 N.S. 
b -0.62 ± 0.45 N.S. N.S. 
c -0.66 ± 0.11 P<0.001 N.S. 
V507I 
(n=6) c -0.74 ± 0.24 P<0.001 N.S. 
N693A 
(n=5) 
a 0.91 ± 0.26 P<0.05 N.S. 
b -0.29 ± 0.09 N.S. N.S. 
c -0.60 ± 0.19 P<0.001 N.S. 
EV 
(n=6) 
a -0.19 ± 0.10 P<0.05 N.C.
N.C.
N.C.
N.C.
N.C.
b -0.11 ± 0.05 N.S. 
c -0.58 ± 0.06 P<0.001 
d -1.14 ± 0.28 N.S
e -1.34 ± 0.36 P<0.05 
N.C. stands for not compared; N.S. stands for no significant difference. Each individual measurement was taken
from one individual cell per coverslip. “n” represents the  number of tested individual cells.
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Figure 1. 
       Fig. 1.  SLC4A11 expression in plasma membrane and H+ Flux. (A) Shows a representative western blot 
image of biotinylated SLC4A11 and (Na+/K+)-ATPase, selected from three independent experiments (n = 3). 
Procedure validation was performed by probing biotinylated and non-biotinylated fractions for GRP94, an ER 
resident protein, and cytosolic GAPDH. Percent in membrane fraction and (SD) are shown. (B) Plot of  
SLC4A11/(Na+/K+)-ATPase ratio for WT and each mutant showing the individual ratios from each experiment, 
the mean and SD, p>0.05.  (C) The measurement of intracellular pH in PS120 cells. Average pHi traces from 
three or more independent experiments as indicated. Pulse with 10 mM NH4Cl was maintained for 300 seconds. 
(D) Baseline pHi. (E) H+ efflux during initial 10 seconds of NH4Cl pulse. (F) H+ influx in the presence of
NH4Cl (between Pulse and Stop). (G) Total acidification which is the difference between baseline pHi and 
lowest pHi after removing NH4Cl. The values represent the average in n=3 tests and are shown as mean+SD. 
One-way ANOVA test in a comparison to WT, * indicates p < 0.05 and ** indicates p < 0.01. 
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Figure 2. 
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Figure 2. Ammonia-induced inward currents in PS120 cells expressing SLC4A11 or its indicated 
mutants.  
A. A sample control trace from an empty vector (EV) expressing PS120 cell. (B-G) Sample traces of NH4Cl-
induced currents observed in PS 120 cells expressing WT-SLC4A11 or mutants. The horizontal lines indicate 
the times when solution pH level was altered and/or NH4Cl was added. The dotted lines show the zero current 
level. Alkalinization of extracellular solution to pH 8.5 induced small inward currents before the second NH4Cl 
pulse in both C386R and W240S mutants. The insets in (A-G) show the current-voltage curves for each trace 
recordings obtained at different pH values. The Summary data of pH 8.5-NH4Cl and pH 7.4-NH4Cl induced 
current densities are shown in (H) and (I). The inset in (H) shows the reversal potential of pH 8.5-NH4Cl and 
pH 7.4-NH4Cl induced  WT, C386R and W240S currents (J) shows the current densities induced by pH 8.5 
solution alone. The peak values at the points when the solution changes from pH 8.5-NH4Cl to pH 8.5 (d point 
in red) and from pH 8.5 to pH 7.4 (e point in red) are shown in (H). The significantly different groups are 
indicated with asterisks. The statistical analysis is included in Table 2. (K) changes in the current flow direction 
upon re-addition of pH 7.5 solution after an NH4Cl extracellular pulse (see points d and e in figure 2B). **, 
p<0.01. NS stands for “not significant.” 
